The proposed project aims to develop new anti-sickling agents to overcome the adverse effects of existing treatments, particularly for pregnant women carrying sickle cell disease. The study aims to reduce vaso occlusions, pain, leg ulcers, infection
Section: Life Sciences & Biotechnology (Research Project)
Related:
Sickle Cell
Sickle Cell Anemia-Phase II
Research Project › Medical Sciences
Design, synthesis,
Design, synthesis, and evaluation of novel dual inhibitors of Angiotensin-II type 1 receptor and Neprilysin for the treatment of diabetic cardiomyopathy
Research Project › Medical Sciences
Design and
Design and Development of Synthetic Bispecific Aptamer Constructs to Redirect T-Cells for Precision Immunotherapy of Oral Squamous Cell Carcinoma
Research Project › Life Sciences & Biotechnology
Study and
Study and design of a cost-effective prosthetic mechanical heart valve
Research Project › Engineering Sciences
Revolutionizing Inflammation
Revolutionizing Inflammation Control: mRNA-LNP-Driven TNFα Antibodies for Treating Inflammatory Bowel Disease
Research Project › Life Sciences & Biotechnology
Accessibility Controls